228177 - Inflammatory Bowel Disease (Answered)

Mr Andrew Smith
To ask the Secretary of State for Health, what funding there has been from the public purse for research into treatment of (a) Crohn's disease and (b) ulcerative colitis in the last five years.

George Freeman

The following table shows expenditure on research relating to the treatment of Crohn’s disease and ulcerative colitis by the Medical Research Council, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.

£ million

2009/10

2010/11

2011/12

2012/13

2013/14

Crohn’s disease

Medical Research Council

3.1

3.4

2.6

2.4

2.5

National Institute for Health Research

0.3

0.4

0.6

0.3

0.8

Ulcerative colitis

Medical Research Council

1.2

1.0

0.9

0.7

0.6

National Institute for Health Research

0.6

0.7

0.9

0.8

1.0

Crohn’s disease and ulcerative colitis

Medical Research Council1

3.6

4.0

3.3

2.9

2.7

Note:

1 Research looking at both Crohn’s disease and ulcerative colitis within the same project.

Total spend by the NIHR on research relating to the treatment of Crohn’s disease and ulcerative colitis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure.